CLINTON GROUP INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
CLINTON GROUP INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$1,279,196,000
+142.9%
14,264
+9.9%
0.20%
+545.2%
Q1 2017$526,599,000
+91802.1%
12,980
-9.0%
0.03%
-6.1%
Q4 2016$573,000
+6.1%
14,258
-4.4%
0.03%
+32.0%
Q3 2016$540,000
+93.5%
14,910
+54.7%
0.02%
+108.3%
Q2 2016$279,0009,6350.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders